Empty Capsules Market

Empty Capsules Market by Type (Gelatin, Non-gelatin), Functionality (Immediate-Release, Sustained-Release, Delayed Release), Therapeutic Application, End User (Pharmaceutical, Nutraceutical, Cosmetic, Reference Laboratories) & Region - Global Forecast to 2028

Report Code: PH 2935 Mar, 2023, by marketsandmarkets.com

The global empty capsules market in terms of revenue was estimated to be worth $3.2 billion in 2023 and is poised to reach $4.9 billion by 2028, growing at a CAGR of 9.3% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of empty capsule market trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. Various elements such as advancements of capsule delivery technologies, and the benefits associated with capsules over other dosage forms, are driving the market growth.

Attractive Opportunities in the Empty Capsules Market

Empty Capsules Market

To know about the assumptions considered for the study, Request for Free Sample Report

Global Empty Capsules Market Dynamics

DRIVER: Increased demand of nutraceuticals is likely to upsurge the market growth

Capsules are one of the preferred dosage forms for delivery of nutraceuticals. Usage of nutraceuticals sage has gained momentum, due to the growing prevalence of non-communicable diseases such as diabetes and cancer. Moreover, personal importance of personal health and wellness is increasing. The continuous rise in the demand for nutraceuticals is further supporting the growth of this market. According to MarketsandMarkets, the nutraceutical ingredients market was valued at USD 185.2 billion in 2022 and is projected to reach USD 261.7 billion by 2027, at a CAGR of 7.2% from 2022 to 2027. Thus, increased demand of nutraceuticals to propel the market growth.

RESTRAINT: Dietary restrictions and cultural practices to hamper the market growth

The most common material used in the empty capsules production is gelatin. Gelatin is prepared from collagen, which is obtained from the by-products of slaughtered animals, including the hides, bones, and hooves of cattle, pigs, fish, horses, and poultry. Many individuals follow cultural practices, in which animal origin-based products are forbidden. In addition, some people have dietary restrictions for animal origin-based products. Thus, these restrictions can potentially hamper the market growth to a certain extent.

OPPORTUNITY: Expansion of capsules manufacturing in emerging countries

The rising investments by pharmaceutical companies in emerging countries are responsible for the growth of the market in the region. Empty capsules manufacturer companies are setting new manufacturing plant and increasing manufacturing capacities in emerging countries. For instance, in February 2021, Qualicaps Europe S.A.U expanded its presence in the South Asia region. In addition to two production sites based in Europe, the company has capsule manufacturing experts located in the EMEA and South Asia. Moreover, in October 2020, Lonza invested USD 93 million (CHF 85 million) in its Capsules and Health Ingredients (CHI) Division, a dosage form delivery partner to the biopharma and health nutrition industry. The investment has been made to expand its overall production capacity of capsules within CHI's Capsugel portfolio by 30 billion capsules annually while maintaining the high-quality standards with Lonza's Sigma Series. The investment is expected to increase its capsule production capacity by 15.0%. Lonza's newest investment will be released to eight sites, including Bornem, Belgium; Colmar, France; Greenwood, South Carolina; Haryana, India; Jakarta, Indonesia; Puebla, Mexico; Sagamihara, Japan; and Suzhou, China. Thus, capacity expansion by major players will lead to growth in the market.

Gelatin capsules segment dominated the Empty Capsules market in 2022.

Based on type, the global empty capsules market is broadly segmented into gelatin capsules and non-gelatin capsules. In 2022, gelatin capsules accounted for the dominant share of the market. This segment's large share can be attributed to factors such as the low cost and availability of gelatin for manufacturing. Furthermore, protein content of gelatin capsules is likely to upsurge the growth of the segment.

The dietary supplements segment of empty capsules market, is expected to grow at the highest CAGR during the forecast period.

Based on therapeutic application, the global empty capsules market is segmented into antibiotic & antibacterial drugs, dietary supplements, antacid & antiflatulent preparations, anti anemic preparations (hematinic), anti-inflammatory drugs, cardiovascular therapy drugs, cough & cold drugs, and other therapeutic applications. The dietary supplements segment is expected to register the highest CAGR during the forecast period. Increased demand of dietary supplements is one of the factors driving the market growth. The availability of dietary supplements is propelling the market growth.

Empty Capsules Market by Region

To know about the assumptions considered for the study, download the pdf brochure

North America dominated Empty Capsules market in 2022.

Geographically, the global empty capsules market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2022, North America accounted for the largest share in market, followed by Europe and the Asia Pacific. The large share of the North American market is owing to various factors such presence of key players and established distribution channels. Increased research for innovative drug delivery formulations is furthermore driving the market growth in North America.

Key players in the Global Empty Capsules market are Capsugel (US), ACG Worldwide (India), Qualicaps (US), CapsCanada Corporation (Canada), Suheung Co. Ltd. (Korea), and Natural Capsules (India).

Empty Capsules Market Report Scope:

Report Metric 

Details 

Market Revenue in 2023

$3.2 billion

Projected Revenue by 2028

$4.9 billion

Revenue Rate

Poised to grow at a CAGR of 9.3%

Market Driver

Increased demand of nutraceuticals is likely to upsurge the market growth

Market Opportunity

Expansion of capsules manufacturing in emerging countries

This report categorizes the global empty capsules market to forecast revenue and analyze trends in each of the following submarkets:

By Type

  • Gelatin Capsules
  • Porcine Gelatin
  • Bovine-derived Gelatin
  • Bone Meal Gelatin
  • Other Gelatin Sources
  • Non-gelatin Capsules
  • Hydroxypropyl Methylcellulose (HPMC)
  • Pullulan & Starch

By Functionality

  • Immediate-release Capsules
  • Sustained-release Capsules
  • Delayed-release Capsules

By Therapeutic Application

  • Antibiotic & antibacterial drugs
  • Dietary supplements
  • Antacid & antiflatulent preparations
  • Antianemic preparations
  • Anti-inflammatory drugs
  • Cardiovascular therapy drugs
  • Cough & cold drugs
  • Other therapeutic applications

By End User

  • Pharmaceutical Industry
  • Nutraceutical Industry
  • Cosmetic Industry
  • Research Laboratories

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Recent Developments

  • In May 2022, Capsugel launched Titanium dioxide-free (TiO2-free) white hard gelatin capsule, which meets the demand of titanium dioxide-free for foods in the European Union.
  • In November 2021, ACG launched a global nutraceutical campaign ‘ACG loves nothing’ to promote problem free nutraceutical production and bring attention to the company’s intention to develop high quality capsules for pharmaceutical and nutraceutical industry.
  • In March 2021, ACG launched ACGcaps NTone and ACGcaps TSafe range of capsules for the nutraceutical market.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 33)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 MARKET SCOPE 
          FIGURE 1 EMPTY CAPSULES MARKET SEGMENTATION
           1.3.1 YEARS CONSIDERED
    1.4 CURRENCY CONSIDERED 
    1.5 LIMITATIONS 
    1.6 STAKEHOLDERS 
    1.7 SUMMARY OF CHANGES 
           1.7.1 RECESSION IMPACT
 
2 RESEARCH METHODOLOGY (Page No. - 37)
    2.1 RESEARCH APPROACH 
          FIGURE 2 RESEARCH DESIGN
           2.1.1 SECONDARY RESEARCH
           2.1.2 PRIMARY RESEARCH
                    FIGURE 3 EMPTY CAPSULES MARKET SIZE: PRIMARY RESPONDENTS
    2.2 MARKET ESTIMATION METHODOLOGY 
          FIGURE 4 MARKET SIZE ESTIMATION, BY VALUE (2022)
          FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2022
          FIGURE 6 MARKET VOLUME ESTIMATION, 2022
           2.2.1 INSIGHTS FROM PRIMARY EXPERTS
                    FIGURE 7 INSIGHTS ON MARKET FROM PRIMARY EXPERTS
    2.3 EMPTY PILLS MARKET: GROWTH RATE PROJECTIONS 
          FIGURE 8 TWO-PIECE EMPTY HARD CAPSULE MARKET ANALYSIS (DEMAND SIDE): GROWTH OF DEMAND-SIDE FACTORS
    2.4 DATA TRIANGULATION 
          FIGURE 9 DATA TRIANGULATION METHODOLOGY
    2.5 RESEARCH ASSUMPTIONS 
    2.6 TWO-PIECE EMPTY HARD CAPSULE MARKET ANALYSIS OF RISK 
 
3 EXECUTIVE SUMMARY (Page No. - 46)
    FIGURE 10 EMPTY CAPSULES MARKET SIZE, BY TYPE, 2023 VS. 2028 (USD MILLION)
    FIGURE 11 FILLABLE CAPSULES MARKET, BY FUNCTIONALITY, 2023 VS. 2028 (USD MILLION)
    FIGURE 12 EMPTY PILLS MARKET, BY THERAPEUTIC APPLICATION, 2023 VS. 2028 (USD MILLION)
    FIGURE 13 MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    FIGURE 14 GEOGRAPHICAL SNAPSHOT OF MARKET
 
4 PREMIUM INSIGHTS (Page No. - 50)
    4.1 EMPTY CAPSULES MARKET OVERVIEW 
          FIGURE 15 INCREASING DEMAND FOR NUTRACEUTICALS TO DRIVE GROWTH
    4.2 NORTH AMERICA: EMPTY PILLS MARKET,  BY TYPE AND COUNTRY (2022) 
          FIGURE 16 GELATIN CAPSULES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
    4.3 MARKET SHARE, BY APPLICATION, 2023 VS. 2028 
          FIGURE 17 ANTIBIOTIC AND ANTIBACTERIAL DRUGS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
    4.4 FILLABLE CAPSULES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 
          FIGURE 18 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
 
5 MARKET OVERVIEW (Page No. - 52)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 19 EMPTY CAPSULES MARKET SIZE: DRIVERS, RESTRAINTS, OPPORTUNITIES,  AND CHALLENGES
          TABLE 1 EMPTY PILLS MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Increasing demand for nutraceuticals
                    5.2.1.2 Growth in pharmaceutical market and increasing number of clinical trials and R&D activities
                    5.2.1.3 Advancements in capsule delivery technologies
                    5.2.1.4 Benefits of capsules over other dosage forms
           5.2.2 RESTRAINTS
                    5.2.2.1 Cultural practices and dietary restrictions
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Expansion of capsule production in emerging countries
                    5.2.3.2 Development of halal gelatin and vegetarian capsules
           5.2.4 CHALLENGES
                    5.2.4.1 Rising prices and lower availability of raw materials in gelatin industry
    5.3 EMPTY CAPSULE MARKET TRENDS / DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 
          FIGURE 20 REVENUE SHIFT AND NEW REVENUE POCKETS
    5.4 TWO-PIECE EMPTY HARD CAPSULE MARKET ANALYSIS OF PRICING 
          TABLE 2 AVERAGE PRICE OF EMPTY CAPSULES, BY REGION (2022)
    5.5 TECHNOLOGY ANALYSIS 
           5.5.1 ENTERIC CAPSULE TECHNOLOGIES
           5.5.2 PROTEIN DELIVERY CAPSULE TECHNOLOGIES
    5.6 VALUE CHAIN ANALYSIS 
          FIGURE 21 FILLABLE CAPSULES MARKET: VALUE CHAIN ANALYSIS
    5.7 TWO-PIECE EMPTY HARD CAPSULE MARKET ANALYSIS OF ECOSYSTEM 
          FIGURE 22 ECOSYSTEM ANALYSIS: MARKET
          TABLE 3 ROLE IN ECOSYSTEM
    5.8 PORTER’S FIVE FORCES ANALYSIS 
          TABLE 4 MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.8.1 THREAT OF NEW ENTRANTS
           5.8.2 THREAT OF SUBSTITUTES
           5.8.3 BARGAINING POWER OF SUPPLIERS
           5.8.4 BARGAINING POWER OF BUYERS
           5.8.5 INTENSITY OF COMPETITIVE RIVALRY
    5.9 KEY STAKEHOLDERS AND BUYING CRITERIA 
          FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF EMPTY CAPSULES
          FIGURE 24 KEY BUYING CRITERIA FOR EMPTY CAPSULES
    5.10 TWO-PIECE EMPTY HARD CAPSULE MARKET ANALYSIS OF PATENT 
           FIGURE 25 PATENT APPLICATIONS RELATED TO EMPTY CAPSULES,  JANUARY 2012–MARCH 2023
           TABLE 5 LIST OF FEW PATENTS IN MARKET
    5.11 TRADE ANALYSIS 
           TABLE 6 EXPORT DATA FOR HS CODE 960200 (TOP 10 COUNTRIES)
           TABLE 7 IMPORT DATA FOR HS CODE 960200 (TOP 10 COUNTRIES)
    5.12 REGULATORY ANALYSIS 
    5.13 PHARMACEUTICAL GELATIN MARKET 
    5.14 EMPTY CAPSULE MARKET TRENDS 
           5.14.1 RISING DEMAND FOR EMPTY CAPSULES IN NUTRACEUTICAL AND COSMETICS INDUSTRIES
           5.14.2 GROWING DEMAND AND ADOPTION OF VEGETARIAN/NON-GELATIN CAPSULES
 
6 GLOBAL EMPTY CAPSULES MARKET SIZE, BY TYPE (Page No. - 72)
    6.1 INTRODUCTION 
          TABLE 8 EMPTY PILLS MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 9 FILLABLE CAPSULES MARKET, BY TYPE, 2021–2028 (BILLION UNITS)
    6.2 GELATIN CAPSULES 
          TABLE 10 GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 11 GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
          TABLE 12 GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (BILLION UNITS)
          TABLE 13 NORTH AMERICA: GELATIN CAPSULES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
          TABLE 14 EUROPE: GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 15 ASIA PACIFIC: GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.1 PORCINE GELATIN
                    6.2.1.1 Porcine gelatin segment to dominate market
                                TABLE 16 PORCINE GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 17 NORTH AMERICA: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                                TABLE 18 EUROPE: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                                TABLE 19 ASIA PACIFIC: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
           6.2.2 BOVINE-DERIVED GELATIN
                    6.2.2.1 Bovine-derived gelatin widely accepted in halal pharmaceuticals market
                                TABLE 20 BOVINE-DERIVED GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 21 NORTH AMERICA: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                                TABLE 22 EUROPE: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                                TABLE 23 ASIA PACIFIC: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
           6.2.3 BONE MEAL
                    6.2.3.1 Bone meal gelatin gained importance in recent years
                                TABLE 24 BONE MEAL GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 25 NORTH AMERICA: BONE MEAL GELATIN CAPSULES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                                TABLE 26 EUROPE: BONE MEAL GELATIN CAPSULES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                                TABLE 27 ASIA PACIFIC: BONE MEAL GELATIN CAPSULES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
           6.2.4 OTHER GELATIN SOURCES
                    TABLE 28 OTHER GELATIN SOURCE CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 29 NORTH AMERICA: OTHER GELATIN SOURCE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 30 EUROPE: OTHER GELATIN SOURCE CAPSULES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 31 ASIA PACIFIC: OTHER GELATIN SOURCE CAPSULES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
    6.3 NON-GELATIN CAPSULES 
          TABLE 32 NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 33 NON-GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
          TABLE 34 NON-GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (BILLION UNITS)
          TABLE 35 NORTH AMERICA: NON-GELATIN CAPSULES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
          TABLE 36 EUROPE: NON-GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 37 ASIA PACIFIC: NON-GELATIN CAPSULES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
           6.3.1 HYDROXYPROPYL METHYLCELLULOSE
                    6.3.1.1 HPMC dominates non-gelatin capsules market
                                TABLE 38 HYDROXYPROPYL METHYLCELLULOSE CAPSULES MARKET, BY REGION,  2021–2028 (USD MILLION)
                                TABLE 39 NORTH AMERICA: HYDROXYPROPYL METHYLCELLULOSE CAPSULES MARKET,  BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 40 EUROPE: HYDROXYPROPYL METHYLCELLULOSE CAPSULES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                                TABLE 41 ASIA PACIFIC: HYDROXYPROPYL METHYLCELLULOSE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.2 PULLULAN AND STARCH
                    6.3.2.1 High manufacturing costs offset advantageous aspects of pullulan and starch
                                TABLE 42 PULLULAN AND STARCH CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 43 NORTH AMERICA: PULLULAN AND STARCH CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 44 EUROPE: PULLULAN AND STARCH CAPSULES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                                TABLE 45 ASIA PACIFIC: PULLULAN AND STARCH CAPSULES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
 
GLOBAL EMPTY CAPSULES MARKET SIZE, BY FUNCTIONALITY (Page No. - 92)
    7.1 INTRODUCTION 
          TABLE 46 EMPTY PILLS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
    7.2 IMMEDIATE-RELEASE CAPSULES 
           7.2.1 INCREASING APPLICATIONS OF IMMEDIATE-RELEASE CAPSULES TO PROPEL MARKET
                    TABLE 47 IMMEDIATE-RELEASE CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 48 NORTH AMERICA: IMMEDIATE-RELEASE CAPSULES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 49 EUROPE: IMMEDIATE-RELEASE CAPSULES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 50 ASIA PACIFIC: IMMEDIATE-RELEASE CAPSULES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
    7.3 SUSTAINED-RELEASE CAPSULES 
           7.3.1 RISING USE OF SUSTAINED-RELEASE FORMULATIONS IN TREATING CHRONIC DISEASES TO DRIVE MARKET
                    TABLE 51 SUSTAINED-RELEASE CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 52 NORTH AMERICA: SUSTAINED-RELEASE CAPSULES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 53 EUROPE: SUSTAINED-RELEASE CAPSULES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 54 ASIA PACIFIC: SUSTAINED-RELEASE CAPSULES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
    7.4 DELAYED-RELEASE CAPSULES 
           7.4.1 GROWING PREFERENCE FOR TARGETED DRUG DELIVERY TO FUEL MARKET GROWTH
                    TABLE 55 DELAYED-RELEASE CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 56 NORTH AMERICA: DELAYED-RELEASE CAPSULES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 57 EUROPE: DELAYED-RELEASE CAPSULES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 58 ASIA PACIFIC: DELAYED-RELEASE CAPSULES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
 
GLOBAL EMPTY CAPSULES MARKET SHARE, BY THERAPEUTIC APPLICATION (Page No. - 100)
    8.1 INTRODUCTION 
          TABLE 59 EMPTY PILLS MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
    8.2 ANTIBIOTIC AND ANTIBACTERIAL DRUGS 
           8.2.1 EMERGENCE OF NOVEL ANTIBIOTICS IN CAPSULE FORM AND INCREASING INCIDENCE OF INFECTIOUS DISEASES TO DRIVE MARKET
                    TABLE 60 MARKET FOR ANTIBIOTIC AND ANTIBACTERIAL DRUGS, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 61 NORTH AMERICA: MARKET FOR ANTIBIOTIC AND ANTIBACTERIAL DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 62 EUROPE: MARKET FOR ANTIBIOTIC AND ANTIBACTERIAL DRUGS,  BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 63 ASIA PACIFIC: MARKET FOR ANTIBIOTIC AND ANTIBACTERIAL DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
    8.3 DIETARY SUPPLEMENTS 
           8.3.1 RISING DEMAND FOR DIETARY SUPPLEMENTS TO SUPPORT GROWTH
                    TABLE 64 MARKET FOR DIETARY SUPPLEMENTS, BY REGION,  2021–2028 (USD MILLION)
                    TABLE 65 NORTH AMERICA: MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 66 EUROPE: MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 67 ASIA PACIFIC: MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2021–2028 (USD MILLION)
    8.4 ANTACID AND ANTIFLATULENT PREPARATIONS 
           8.4.1 INCREASING DEMAND FOR GASTROINTESTINAL FORMULATIONS TO DRIVE MARKET
                    TABLE 68 MARKET FOR ANTACID AND ANTIFLATULENT PREPARATIONS,  BY REGION, 2021–2028 (USD MILLION)
                    TABLE 69 NORTH AMERICA: MARKET FOR ANTACID AND ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 70 EUROPE: MARKET FOR ANTACID AND ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 71 ASIA PACIFIC: MARKET FOR ANTACID AND ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
    8.5 ANTIANEMIC PREPARATIONS 
           8.5.1 RISING INCIDENCE OF ANEMIA WORLDWIDE TO DRIVE GROWTH
                    TABLE 72 EMPTY CAPSULES MARKET SHARE FOR ANTIANEMIC PREPARATIONS, BY REGION,  2021–2028 (USD MILLION)
                    TABLE 73 NORTH AMERICA: MARKET FOR ANTIANEMIC PREPARATIONS,  BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 74 EUROPE: MARKET FOR ANTIANEMIC PREPARATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 75 ASIA PACIFIC: MARKET FOR ANTIANEMIC PREPARATIONS,  BY COUNTRY, 2021–2028 (USD MILLION)
    8.6 ANTI-INFLAMMATORY DRUGS 
           8.6.1 RISING EMPHASIS ON GENERICS TO FAVOR MARKET GROWTH
                    TABLE 76 FILLABLE CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY REGION,  2021–2028 (USD MILLION)
                    TABLE 77 NORTH AMERICA: MARKET FOR ANTI-INFLAMMATORY DRUGS,  BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 78 EUROPE: MARKET FOR ANTI-INFLAMMATORY DRUGS,  BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 79 ASIA PACIFIC: MARKET FOR ANTI-INFLAMMATORY DRUGS,  BY COUNTRY, 2021–2028 (USD MILLION)
    8.7 CARDIOVASCULAR THERAPY DRUGS 
           8.7.1 RISING PREVALENCE OF CARDIOVASCULAR DISEASES TO CONTRIBUTE TO MARKET GROWTH
                    TABLE 80 MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY REGION,  2021–2028 (USD MILLION)
                    TABLE 81 NORTH AMERICA: MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 82 EUROPE: MARKET FOR CARDIOVASCULAR THERAPY DRUGS,  BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 83 ASIA PACIFIC: MARKET FOR CARDIOVASCULAR THERAPY DRUGS,  BY COUNTRY, 2021–2028 (USD MILLION)
    8.8 COUGH AND COLD DRUGS 
           8.8.1 GROWING ADOPTION OF OTC FORMULATIONS AND SELF-MEDICATION PRACTICES TO DRIVE GROWTH
                    TABLE 84 MARKET FOR COUGH AND COLD DRUGS, BY REGION,  2021–2028 (USD MILLION)
                    TABLE 85 NORTH AMERICA: MARKET FOR COUGH AND COLD DRUGS,  BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 86 EUROPE: MARKET FOR COUGH AND COLD DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 87 ASIA PACIFIC: MARKET FOR COUGH AND COLD DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
    8.9 OTHER THERAPEUTIC APPLICATIONS 
          TABLE 88 MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
          TABLE 89 NORTH AMERICA: MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 90 EUROPE: MARKET FOR OTHER THERAPEUTIC APPLICATIONS,  BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 91 ASIA PACIFIC: MARKET FOR OTHER THERAPEUTIC APPLICATIONS,  BY COUNTRY, 2021–2028 (USD MILLION)
 
GLOBAL EMPTY CAPSULES MARKET SHARE, BY END USER (Page No. - 118)
    9.1 INTRODUCTION 
          TABLE 92 EMPTY PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)
    9.2 PHARMACEUTICAL INDUSTRY 
           9.2.1 INCREASING EMPHASIS ON DRUG DEVELOPMENT TO DRIVE GROWTH
                    TABLE 93 MARKET FOR PHARMACEUTICAL INDUSTRY, BY REGION,  2021–2028 (USD MILLION)
                    TABLE 94 NORTH AMERICA: MARKET FOR PHARMACEUTICAL INDUSTRY,  BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 95 EUROPE: MARKET FOR PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 96 ASIA PACIFIC: MARKET FOR PHARMACEUTICAL INDUSTRY,  BY COUNTRY, 2021–2028 (USD MILLION)
    9.3 NUTRACEUTICAL INDUSTRY 
           9.3.1 INCREASING DEMAND FOR DIETARY SUPPLEMENTS IN DEVELOPED AND DEVELOPING COUNTRIES TO SUPPORT GROWTH
                    TABLE 97 MARKET FOR NUTRACEUTICAL INDUSTRY, BY REGION,  2021–2028 (USD MILLION)
                    TABLE 98 NORTH AMERICA: MARKET FOR NUTRACEUTICAL INDUSTRY,  BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 99 EUROPE: MARKET FOR NUTRACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 100 ASIA PACIFIC: MARKET FOR NUTRACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
    9.4 COSMETICS INDUSTRY 
           9.4.1 GELATIN-BASED CAPSULES ARE IDEAL FOR DELIVERING COSMETIC PRODUCTS
                    TABLE 101 FILLABLE CAPSULES MARKET FOR COSMETICS INDUSTRY, BY REGION,  2021–2028 (USD MILLION)
                    TABLE 102 NORTH AMERICA: MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 103 EUROPE: MARKET FOR COSMETICS INDUSTRY, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 104 ASIA PACIFIC: MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
    9.5 RESEARCH LABORATORIES 
           9.5.1 RISING CLINICAL TRIAL ACTIVITY TO DRIVE MARKET GROWTH
                    TABLE 105 MARKET FOR RESEARCH LABORATORIES, BY REGION,  2021–2028 (USD MILLION)
                    TABLE 106 NORTH AMERICA: MARKET FOR RESEARCH LABORATORIES,  BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 107 EUROPE: MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 108 ASIA PACIFIC: MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
 
10 GLOBAL EMPTY CAPSULES MARKET SHARE, BY REGION (Page No. - 128)
     10.1 INTRODUCTION 
             TABLE 109 EMPTY PILLS MARKET, BY REGION, 2021–2028 (USD MILLION)
             TABLE 110 MARKET, BY REGION, 2021–2028 (BILLION UNITS)
     10.2 NORTH AMERICA 
             FIGURE 26 NORTH AMERICA: EMPTY CAPSULES MARKET SNAPSHOT
             TABLE 111 NORTH AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 112 NORTH AMERICA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 113 NORTH AMERICA: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 114 NORTH AMERICA: NON-GELATIN CAPSULES MARKET, BY TYPE,  2021–2028 (USD MILLION)
             TABLE 115 NORTH AMERICA: MARKET, BY FUNCTIONALITY,  2021–2028 (USD MILLION)
             TABLE 116 NORTH AMERICA: MARKET, BY THERAPEUTIC APPLICATION,  2021–2028 (USD MILLION)
             TABLE 117 NORTH AMERICA: FILLABLE CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.2.1 US
                        10.2.1.1 US to dominate North American market during forecast period
                                      TABLE 118 US: EMPTY CAPSULES MARKET SHARE, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 119 US: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 120 US: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 121 US: MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                                      TABLE 122 US: MARKET, BY THERAPEUTIC APPLICATION,  2021–2028 (USD MILLION)
                                      TABLE 123 US: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.2.2 CANADA
                        10.2.2.1 Rising government focus on utilization of generics as means for controlling healthcare expenditure to drive growth
                                      TABLE 124 CANADA: EMPTY CAPSULES MARKET FORECAST, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 125 CANADA: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 126 CANADA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 127 CANADA: MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                                      TABLE 128 CANADA: EMPTY CAPSULES MARKET PREDICTION, BY THERAPEUTIC APPLICATION,  2021–2028 (USD MILLION)
                                      TABLE 129 CANADA: EMPTY PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.2.3 NORTH AMERICA: RECESSION IMPACT
     10.3 EUROPE 
             TABLE 130 EUROPE: EMPTY CAPSULES MARKET FORECAST, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 131 EUROPE: MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 132 EUROPE: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 133 EUROPE: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 134 EUROPE: MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
             TABLE 135 EUROPE: EMPTY CAPSULES MARKET PREDICTION, BY THERAPEUTIC APPLICATION,  2021–2028 (USD MILLION)
             TABLE 136 EUROPE: FILLABLE CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.3.1 GERMANY
                        10.3.1.1 Presence of large number of pharmaceutical and nutraceutical manufacturers propelling demand for empty capsules
                                      TABLE 137 GERMANY: EMPTY CAPSULES MARKET FORECAST, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 138 GERMANY: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 139 GERMANY: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 140 GERMANY: MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                                      TABLE 141 GERMANY: MARKET, BY THERAPEUTIC APPLICATION,  2021–2028 (USD MILLION)
                                      TABLE 142 GERMANY: EMPTY CAPSULES MARKET PREDICTION, BY END USER, 2021–2028 (USD MILLION)
             10.3.2 UK
                        10.3.2.1 Rising adoption of generics to drive market growth
                                      TABLE 143 UK: EMPTY CAPSULES MARKET FORECAST, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 144 UK: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 145 UK: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 146 UK: MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                                      TABLE 147 UK: EMPTY CAPSULES MARKET PREDICTION, BY THERAPEUTIC APPLICATION,  2021–2028 (USD MILLION)
                                      TABLE 148 UK: EMPTY PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.3.3 FRANCE
                        10.3.3.1 High demand for pharmaceutical products to drive market growth
                                      TABLE 149 FRANCE: EMPTY CAPSULES MARKET FORECAST, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 150 FRANCE: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 151 FRANCE: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 152 FRANCE: MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                                      TABLE 153 FRANCE: EMPTY CAPSULES MARKET PREDICTION, BY THERAPEUTIC APPLICATION,  2021–2028 (USD MILLION)
                                      TABLE 154 FRANCE: FILLABLE CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.3.4 ITALY
                        10.3.4.1 Growing presence of small and medium-sized CMOs likely to drive market
                                      TABLE 155 ITALY: EMPTY CAPSULES MARKET TRENDS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 156 ITALY: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 157 ITALY: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 158 ITALY: MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                                      TABLE 159 ITALY: MARKET, BY THERAPEUTIC APPLICATION,  2021–2028 (USD MILLION)
                                      TABLE 160 ITALY: EMPTY CAPSULES MARKET SEGMENTATION, BY END USER, 2021–2028 (USD MILLION)
             10.3.5 SPAIN
                        10.3.5.1 Consolidation of biotechnology sector and availability of government support to drive growth
                                      TABLE 161 SPAIN: EMPTY CAPSULES MARKET TRENDS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 162 SPAIN: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 163 SPAIN: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 164 SPAIN: MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                                      TABLE 165 SPAIN: EMPTY CAPSULES MARKET SEGMENTATION, BY THERAPEUTIC APPLICATION,  2021–2028 (USD MILLION)
                                      TABLE 166 SPAIN: EMPTY PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.3.6 REST OF EUROPE
                        TABLE 167 REST OF EUROPE: EMPTY CAPSULES MARKET TRENDS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 168 REST OF EUROPE: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 169 REST OF EUROPE: NON-GELATIN CAPSULES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 170 REST OF EUROPE: MARKET, BY FUNCTIONALITY,  2021–2028 (USD MILLION)
                        TABLE 171 REST OF EUROPE: EMPTY CAPSULES MARKET SEGMENTATION, BY THERAPEUTIC APPLICATION,  2021–2028 (USD MILLION)
                        TABLE 172 REST OF EUROPE: FILLABLE CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.3.7 EUROPE: RECESSION IMPACT
     10.4 ASIA PACIFIC 
             FIGURE 27 ASIA PACIFIC: EMPTY CAPSULES MARKET SNAPSHOT
             TABLE 173 ASIA PACIFIC: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 174 ASIA PACIFIC: MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 175 ASIA PACIFIC: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 176 ASIA PACIFIC: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 177 ASIA PACIFIC: MARKET, BY FUNCTIONALITY,  2021–2028 (USD MILLION)
             TABLE 178 ASIA PACIFIC: MARKET, BY THERAPEUTIC APPLICATION,  2021–2028 (USD MILLION)
             TABLE 179 ASIA PACIFIC: EMPTY CAPSULES MARKET SEGMENTATION, BY END USER, 2021–2028 (USD MILLION)
             10.4.1 CHINA
                        10.4.1.1 Low manufacturing costs on account of availability of raw materials to accelerate growth
                                      TABLE 180 CHINA: EMPTY CAPSULES MARKET TRENDS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 181 CHINA: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 182 CHINA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 183 CHINA: MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                                      TABLE 184 CHINA: EMPTY CAPSULES MARKET SEGMENTATION, BY THERAPEUTIC APPLICATION,  2021–2028 (USD MILLION)
                                      TABLE 185 CHINA: EMPTY PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.4.2 JAPAN
                        10.4.2.1 Japan to be largest market for empty capsules in Asia Pacific
                                      TABLE 186 JAPAN: EMPTY CAPSULES MARKET TRENDS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 187 JAPAN: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 188 JAPAN: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 189 JAPAN: MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                                      TABLE 190 JAPAN: EMPTY CAPSULES MARKET GROWTH, BY THERAPEUTIC APPLICATION,  2021–2028 (USD MILLION)
                                      TABLE 191 JAPAN: FILLABLE CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.4.3 INDIA
                        10.4.3.1 Increased exports of empty capsules to drive market growth
                                      TABLE 192 INDIA: EMPTY CAPSULES MARKET OVERVIEW, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 193 INDIA: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 194 INDIA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 195 INDIA: MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                                      TABLE 196 INDIA: MARKET, BY THERAPEUTIC APPLICATION,  2021–2028 (USD MILLION)
                                      TABLE 197 INDIA: EMPTY CAPSULES MARKET GROWTH, BY END USER, 2021–2028 (USD MILLION)
             10.4.4 REST OF ASIA PACIFIC
                        TABLE 198 REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET OVERVIEW, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 199 REST OF ASIA PACIFIC: GELATIN CAPSULES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 200 REST OF ASIA PACIFIC: NON-GELATIN CAPSULES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 201 REST OF ASIA PACIFIC: MARKET, BY FUNCTIONALITY,  2021–2028 (USD MILLION)
                        TABLE 202 REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET GROWTH, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 203 REST OF ASIA PACIFIC: EMPTY PILLS MARKET, BY END USER,  2021–2028 (USD MILLION)
             10.4.5 ASIA PACIFIC: RECESSION IMPACT
     10.5 LATIN AMERICA 
             10.5.1 STRATEGIC EXPANSIONS BY LEADING MARKET PLAYERS TO DRIVE GROWTH
                        TABLE 204 LATIN AMERICA: EMPTY CAPSULES MARKET OVERVIEW, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 205 LATIN AMERICA: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 206 LATIN AMERICA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 207 LATIN AMERICA: MARKET, BY FUNCTIONALITY,  2021–2028 (USD MILLION)
                        TABLE 208 LATIN AMERICA: EMPTY CAPSULES MARKET GROWTH, BY THERAPEUTIC APPLICATION,  2021–2028 (USD MILLION)
                        TABLE 209 LATIN AMERICA: FILLABLE CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.5.2 LATIN AMERICA: RECESSION IMPACT
     10.6 MIDDLE EAST & AFRICA 
             10.6.1 GROWING PHARMACEUTICAL INDUSTRY TO DRIVE MARKET
                        TABLE 210 MIDDLE EAST & AFRICA: EMPTY CAPSULES MARKET OVERVIEW, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 211 MIDDLE EAST & AFRICA: GELATIN CAPSULES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 212 MIDDLE EAST & AFRICA: NON-GELATIN CAPSULES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 213 MIDDLE EAST & AFRICA: MARKET, BY FUNCTIONALITY,  2021–2028 (USD MILLION)
                        TABLE 214 MIDDLE EAST & AFRICA: MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 215 MIDDLE EAST & AFRICA: EMPTY CAPSULES MARKET GROWTH, BY END USER,  2021–2028 (USD MILLION)
             10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
 
11 COMPETITIVE LANDSCAPE (Page No. - 183)
     11.1 INTRODUCTION 
     11.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS 
             FIGURE 28 GLOBAL EMPTY CAPSULES MARKET OVERVIEW: STRATEGIES ADOPTED
     11.3 TWO-PIECE EMPTY HARD CAPSULE MARKET ANALYSIS FOR MARKET SHARE
             FIGURE 29 TWO-PIECE EMPTY HARD CAPSULE MARKET ANALYSIS OF MARKET SHARE, BY KEY PLAYER (2022)
             TABLE 216 EMPTY PILLS MARKET: DEGREE OF COMPETITION
     11.4 REVENUE ANALYSIS 
             FIGURE 30 TWO-PIECE EMPTY HARD CAPSULE MARKET ANALYSIS OF REVENUE FOR KEY COMPANIES (2020–2022)
     11.5 COMPANY EVALUATION MATRIX 
             11.5.1 STARS
             11.5.2 EMERGING LEADERS
             11.5.3 PERVASIVE PLAYERS
             11.5.4 PARTICIPANTS
                        FIGURE 31 FILLABLE CAPSULES MARKET: COMPANY EVALUATION MATRIX, 2022
     11.6 COMPANY EVALUATION MATRIX FOR START-UPS/SMES 
             11.6.1 PROGRESSIVE COMPANIES
             11.6.2 STARTING BLOCKS
             11.6.3 RESPONSIVE COMPANIES
             11.6.4 DYNAMIC COMPANIES
                        FIGURE 32 MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022
     11.7 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS 
             11.7.1 OVERALL COMPANY FOOTPRINT (25 COMPANIES)
                        TABLE 217 TWO-PIECE EMPTY HARD CAPSULE MARKET ANALYSIS OF OVERALL FOOTPRINT OF KEY PLAYERS
             11.7.2 INDUSTRY FOOTPRINT OF COMPANIES (25 COMPANIES)
                        TABLE 218 TWO-PIECE EMPTY HARD CAPSULE MARKET ANALYSIS OF INDUSTRY FOOTPRINT OF KEY PLAYERS
             11.7.3 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES)
                        TABLE 219 TWO-PIECE EMPTY HARD CAPSULE MARKET ANALYSIS OF REGIONAL FOOTPRINT OF KEY PLAYERS
             11.7.4 OFFERING FOOTPRINT OF COMPANIES (25 COMPANIES)
                        TABLE 220 TWO-PIECE EMPTY HARD CAPSULE MARKET ANALYSIS OF OFFERING FOOTPRINT OF KEY PLAYERS
     11.8 COMPETITIVE BENCHMARKING OF START-UPS/SMES 
             TABLE 221 EMPTY PILLS MARKET: DETAILED LIST OF KEY START-UPS/SMES
             TABLE 222 MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SMES
     11.9 COMPETITIVE SCENARIO AND EMPTY CAPSULE MARKET TRENDS 
             11.9.1 PRODUCT LAUNCHES
                        TABLE 223 FILLABLE CAPSULES MARKET: PRODUCT LAUNCHES, JANUARY 2020–MARCH 2023
             11.9.2 DEALS
                        TABLE 224 MARKET: DEALS, JANUARY 2020–MARCH 2023
             11.9.3 OTHER DEVELOPMENTS
                        TABLE 225 EMPTY PILLS MARKET: OTHER DEVELOPMENTS, JANUARY 2020–MARCH 2023
 
12 COMPANY PROFILES (Page No. - 198)
(Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) *
     12.1 KEY PLAYERS 
             12.1.1 CAPSUGEL (LONZA GROUP LTD.)
                        TABLE 226 CAPSUGEL (LONZA GROUP): BUSINESS OVERVIEW
                        FIGURE 33 LONZA GROUP LTD.: COMPANY SNAPSHOT (2022)
             12.1.2 ACG
                        TABLE 227 ACG: BUSINESS OVERVIEW
             12.1.3 MITSUBISHI CHEMICAL HOLDINGS CORPORATION
                        TABLE 228 QUALICAPS (MITSUBISHI CHEMICAL HOLDINGS CORPORATION): BUSINESS OVERVIEW
                        FIGURE 34 QUALICAPS (MITSUBISHI CHEMICAL HOLDINGS CORPORATION):  COMPANY SNAPSHOT (2021)
             12.1.4 CAPSCANADA CORPORATION
                        TABLE 229 CAPSCANADA CORPORATION: BUSINESS OVERVIEW
             12.1.5 NATURAL CAPSULES
                        TABLE 230 NATURAL CAPSULES: BUSINESS OVERVIEW
                        FIGURE 35 NATURAL CAPSULES: COMPANY SNAPSHOT (2021)
             12.1.6 SUHEUNG
                        TABLE 231 SUHEUNG: BUSINESS OVERVIEW
             12.1.7 NECTAR LIFESCIENCES LTD.
                        TABLE 232 NECTAR LIFESCIENCES LTD.: BUSINESS OVERVIEW
                        FIGURE 36 NECTAR LIFESCIENCES LTD.: COMPANY SNAPSHOT (2021)
             12.1.8 QINGDAO YIQING MEDICINAL CAPSULE (BAOTOU DONGBAO BIOTECHNOLOGY CO., LTD.)
                        TABLE 233 QINGDAO YIQING MEDICINAL CAPSULE: BUSINESS OVERVIEW
             12.1.9 SHANXI GUANGSHENG MEDICINAL CAPSULE
                        TABLE 234 SHANXI GUANGSHENG MEDICINAL CAPSULE: BUSINESS OVERVIEW
             12.1.10 HEALTHCAPS INDIA
                        TABLE 235 HEALTHCAPS INDIA: BUSINESS OVERVIEW
             12.1.11 MEDI-CAPS
                        TABLE 236 MEDI-CAPS: BUSINESS OVERVIEW
                        FIGURE 37 MEDI-CAPS: COMPANY SNAPSHOT (2021)
             12.1.12 SNAIL PHARMA INDUSTRY
                        TABLE 237 SNAIL PHARMA INDUSTRY: BUSINESS OVERVIEW
             12.1.13 ROXLOR
                        TABLE 238 ROXLOR: BUSINESS OVERVIEW
             12.1.14 SUNIL HEALTHCARE
                        TABLE 239 SUNIL HEALTHCARE: BUSINESS OVERVIEW
                        FIGURE 38 SUNIL HEALTHCARE: COMPANY SNAPSHOT (2021)
             12.1.15 BIOCAPS ENTERPRISE
                        TABLE 240 BIOCAPS ENTERPRISE: BUSINESS OVERVIEW
             12.1.16 BRIGHT PHARMA CAPS
                        TABLE 241 BRIGHT PHARMA CAPS: BUSINESS OVERVIEW
     12.2 OTHER COMPANIES 
             12.2.1 COMED CHEMICALS
                        TABLE 242 COMED CHEMICALS: BUSINESS OVERVIEW
             12.2.2 SAVIOUR CAPS
                        TABLE 243 SAVIOUR CAPS: BUSINESS OVERVIEW
             12.2.3 FORTCAPS HEALTHCARE
                        TABLE 244 FORTCAPS HEALTHCARE: BUSINESS OVERVIEW
             12.2.4 SHAOXING ZHONGYA CAPSULE
                        TABLE 245 SHAOXING ZHONGYA CAPSULE: BUSINESS OVERVIEW
             12.2.5 ERAWAT PHARMA LIMITED
                        TABLE 246 ERAWAT PHARMA LIMITED: BUSINESS OVERVIEW
             12.2.6 FARMACAPSULAS
                        TABLE 247 FARMACAPSULAS: BUSINESS OVERVIEW
             12.2.7 ZHEJIANG YUEXI CAPSULE
             12.2.8 LFA MACHINES OXFORD
             12.2.9 SHAOXING KANGKE CAPSULE
             12.2.10 SHREE PHARMA CAPS
 
*Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.
 
13 APPENDIX (Page No. - 241)
     13.1 DISCUSSION GUIDE 
     13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     13.3 CUSTOMIZATION OPTIONS 
     13.4 RELATED REPORTS 
     13.5 AUTHOR DETAILS 

Research for this study involved estimating the current size and forecast of the global empty capsules market through secondary and primary research. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent markets. The next step was to validate these findings & assumptions with industry experts across the value chain through primary research. The market estimates arrived by top-down and other approaches were triangulated to estimate the market size of segments and subsegments. Market growth forecasts were derived by developing assumptions based on revenue growth & key developments from major market players, industry drivers and inputs from demand and supply side experts.

Secondary Research

The secondary sources referred to for this research study include publications from government and private sources such as the European Federation of Pharmaceutical Industries and Associations (EFPIA), , Pharmaceutical Research and Manufacturers of America (PhRMA), Indian Pharmaceutical Association (IPA), Indian Drug Manufacturers’ Association, Generics and Biosimilars Initiative (GaBI), International Alliance of Dietary/Food Supplement Associations (IADSA), Drug- Chemical & Associated Technologies Association (DCAT), World Health Organization (WHO), US FDA, Company Websites, Annual Reports, SEC Filings, Press Releases, Investor Presentations, Journals, Expert Interviews, and MarketsandMarkets Analysis. Secondary data was collected and analyzed to arrive at the overall size of the global empty capsules market, which was then validated by primary research.

Primary Research

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

Empty Capsules Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Top-down approach was used to estimate and validate the total size of the global empty capsules market. This method was also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and market have been identified through extensive secondary research
  • The revenues generated from the empty capsules business of leading players have been determined through primary and secondary research
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Data Triangulation

After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and global empty capsule market trends from both the demand and supply sides.

Report Objectives

  • To define, describe, and forecast the global empty capsules market based on the type, functionality, therapeutic application, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, challenges, and opportunities)
  • To strategically analyze micromarkets with respect to individual growth of empty capsule market trends, future prospects, and contributions to the overall market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
  • To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze competitive developments such as acquisitions, expansions, agreements, collaborations, and R&D activities in the global empty capsules market.

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Geographic Analysis

  • Further breakdown of the Rest of Europe empty capsules market into respective countries
  • Further breakdown of the Rest of Asia Pacific empty capsules market into respective countries

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)

Company Information

  • An additional five company profiles
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
PH 2935
Published ON
Mar, 2023
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Empty Capsules Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback